Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Christenson

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Oncology Reports|July 5, 2022
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?Eric S Christenson, Jeffrey Meyer
Expert Opinion on Emerging Drugs|March 30, 2018
PARP inhibitors for homologous recombination-deficient prostate cancerEric S Christenson, Emmanuel S Antonarakis
The American Journal of Medicine|February 10, 2015
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious SequelaeEric S Christenson, Colin Ligon, Steven Hsu
JCO Oncology Practice|December 4, 2025
Total Neoadjuvant Treatment: A Dynamite Approach in the Treatment of Locally Advanced Rectal CancerHarrison D Winters, Jeffrey Meyer, Eric S Christenson
JCO Oncology Practice|May 20, 2026
Considerations of Wait Intervals and Neoadjuvant Windows in Rectal CancerHarrison D Winters, Jeffrey Meyer, Eric S Christenson
Case Reports in Oncology|April 8, 2015
Tyrosine kinase inhibitor induced isolated pericardial effusionVineet Agrawal, Eric S Christenson, Margaret M Showel
The Lancet. Oncology|March 6, 2020
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright futureEric S Christenson, Elizabeth Jaffee, Nilofer S Azad
Expert Review of Clinical Immunology|May 1, 2024
Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategiesYi Jin, Eric S Christenson, Lei Zheng, et al.
The Lancet. Infectious Diseases|December 4, 2014
Pasteurella multocida infection in solid organ transplantationEric S Christenson, Haitham M Ahmed, Christine M Durand
Clinical Biochemistry|December 3, 2014
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicityEric S Christenson, Theodore James, Vineet Agrawal, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Oncology Reports|July 5, 2022
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?Eric S Christenson, Jeffrey Meyer
Expert Opinion on Emerging Drugs|March 30, 2018
PARP inhibitors for homologous recombination-deficient prostate cancerEric S Christenson, Emmanuel S Antonarakis
The American Journal of Medicine|February 10, 2015
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious SequelaeEric S Christenson, Colin Ligon, Steven Hsu
JCO Oncology Practice|December 4, 2025
Total Neoadjuvant Treatment: A Dynamite Approach in the Treatment of Locally Advanced Rectal CancerHarrison D Winters, Jeffrey Meyer, Eric S Christenson
JCO Oncology Practice|May 20, 2026
Considerations of Wait Intervals and Neoadjuvant Windows in Rectal CancerHarrison D Winters, Jeffrey Meyer, Eric S Christenson
Case Reports in Oncology|April 8, 2015
Tyrosine kinase inhibitor induced isolated pericardial effusionVineet Agrawal, Eric S Christenson, Margaret M Showel
The Lancet. Oncology|March 6, 2020
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright futureEric S Christenson, Elizabeth Jaffee, Nilofer S Azad
Expert Review of Clinical Immunology|May 1, 2024
Neutrophils in pancreatic ductal adenocarcinoma: bridging preclinical insights to clinical prospects for improved therapeutic strategiesYi Jin, Eric S Christenson, Lei Zheng, et al.
The Lancet. Infectious Diseases|December 4, 2014
Pasteurella multocida infection in solid organ transplantationEric S Christenson, Haitham M Ahmed, Christine M Durand
Clinical Biochemistry|December 3, 2014
Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicityEric S Christenson, Theodore James, Vineet Agrawal, et al.
Pageof 5